نتایج جستجو برای: pyrazinamide pza

تعداد نتایج: 1701  

Journal: :Journal of clinical microbiology 2001
M M Hannan E P Desmond G P Morlock G H Mazurek J T Crawford

Mycobacterium bovis is naturally resistant to the antituberculosis drug pyrazinamide (PZA). To determine whether all Mycobacterium tuberculosis complex isolates demonstrating PZA monoresistance were truly M. bovis, we examined the phenotype and genotype of isolates reported as PZA monoresistant in five counties in California from January 1996 through June 1999. Isolates reported by local labora...

Journal: :Antimicrobial agents and chemotherapy 2000
A M Lenaerts S E Chase M H Cynamon

The newer rifamycin, rifalazil (RLZ) (previously known as KRM-1648), has been shown in prior experiments to be a highly potent drug against Mycobacterium tuberculosis. In this report, we studied the efficacy of RLZ in combination with pyrazinamide (PZA) and ethambutol (EMB) in a long-term in vivo experiment and compared their activity with the isoniazid (INH)-rifampin (RIF) combination which is...

Journal: :Journal of clinical microbiology 2013
Claudio Piersimoni Alessandro Mustazzolu Federico Giannoni Stefano Bornigia Giancarlo Gherardi Lanfranco Fattorini

The susceptibility of 211 clinical isolates of Mycobacterium tuberculosis complex (201 M. tuberculosis and 10 Mycobacterium bovis isolates) to pyrazinamide (PZA) was assessed by the nonradiometric Bactec MGIT 960 system (M960). Detection of PZA resistance was followed by a repeat testing using a reduced inoculum (RI) of 0.25 ml instead of 0.5 ml. According to the first M960 analysis, resistance...

Journal: :Antimicrobial agents and chemotherapy 2005
Mark T McCammon John S Gillette Derek P Thomas Srinivas V Ramaswamy Ishmael I Rosas Edward A Graviss Jan Vijg Teresa N Quitugua

Denaturing gradient gel electrophoresis (DGGE) was used to probe for mutations associated with pyrazinamide (PZA) resistance in the pncA gene of Mycobacterium tuberculosis. DGGE scans for mutations across large regions of DNA and rivals sequencing in its ability to detect DNA alterations. Specific mutations can often be recognized by their characteristic denaturation pattern, which serves as a ...

2017
Jean Claude Semuto Ngabonziza Awa Ba Diallo Elisa Tagliani Bassirou Diarra Abalo Essosimna Kadanga Antieme Combo George Togo Aliou Thiam Willem Bram de Rijk Riccardo Alagna Sabine Houeto Fatoumata Ba Anoumou Yaotsè Dagnra Emil Ivan Dissou Affolabi Valérie Schwoebel Arnaud Trebucq Bouke Catherine de Jong Leen Rigouts Géraldine Daneau

BACKGROUND Besides inclusion in 1st line regimens against tuberculosis (TB), pyrazinamide (PZA) is used in 2nd line anti-TB regimens, including in the short regimen for multidrug-resistant TB (MDR-TB) patients. Guidelines and expert opinions are contradictory about inclusion of PZA in case of resistance. Moreover, drug susceptibility testing (DST) for PZA is not often applied in routine testing...

2016
Vaishali R Wabale

Pyrazinamide (PZA) is a nicotinamide analog that is used as a frontline drug to treat tuberculosis (TB). It has special place in modern TB therapy, as it appears to kill a population of semi dormant tubercle bacilli persisting in the body. It is important drug because of its sterilizing activity against semi dormant tubercle bacilli. Although PZA has a very high in vivo activity, it’s in vitro ...

Journal: :Indian pediatrics 2012
V Roy P Sahni P Gupta G R Sethi A Khanna

OBJECTIVES To evaluate the blood levels, pharma-cokinetics and pharmacodynamic indices of pyrazinamide (PZA) in children suffering from tuberculosis, at doses administered under the weight band system of Revised National Tuberculosis Control Program of India (RNTCP) of India. DESIGN Prospective, open-label, non-randomized single-dose study. SETTING 20 children in the age group 5-12 years at...

Journal: :Antimicrobial agents and chemotherapy 2016
Jean-Philippe Lanoix Thomas Ioerger Aimee Ormond Firat Kaya James Sacchettini Véronique Dartois Eric Nuermberger

Pyrazinamide (PZA) is one of only two sterilizing drugs in the first-line antituberculosis regimen. Its activity is strongly pH dependent; the MIC changes by several orders of magnitude over a range of pH values that may be encountered in various in vivo compartments. We recently reported selective inactivity of PZA in a subset of C3HeB/FeJ mice with large caseous lung lesions. In the present s...

2017
Yu Pang Damian Zhu Huiwen Zheng Jing Shen Yan Hu Jie Liu Yanlin Zhao

BACKGROUND Pyrazinamide (PZA) plays a unique role in the treatment for multidrug-resistant tuberculosis (MDR-TB) in both first- and second-line regimens. The aim of this study was to investigate the prevalence and molecular characterization of PZA resistance among MDR-TB isolates collected in Chongqing municipality. METHODS A total of 133 MDR-TB isolates were collected from the smear-positive...

Journal: :Antimicrobial agents and chemotherapy 1996
R Frothingham W A Meeker-O'Connell E A Talbot J W George K N Kreuzer

Pyrazinamide (PZA) is one of the three most important drugs for treatment of Mycobacterium tuberculosis infections. The antibacterial activity of PZA requires a bacterial enzyme, pyrazinamidase (PZAase), which hydrolyzes PZA to form pyrazinoic acid and ammonia. Most PZA-resistant clinical M. tuberculosis isolates lack PZAase activity. With the goal of eventually identifying and characterizing t...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید